Search results

230 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Nelson named President of Medical Foundation of North Carolina, Associate Dean for Development at the UNC School of Medicine
Leslie H. Nelson has been named as President of the Medical Foundation of North Carolina and Associate Dean for Development of the UNC School of Medicine effective Jan. 1, 2018. The Medical Foundation of North Carolina is the not-for-profit, philanthropic arm of the UNC School of Medicine and UNC Hospitals.
Located in Employee News Online / 2017 / Dec. 21
New models of kidney cancer may drive immunotherapy research
UNC Lineberger member William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers.
Located in News / 2017 / June
New School of Medicine Program Highlights Precision Medicine at UNC
The Program for Precision Medicine in Health Care will be led by the UNC School of Medicine’s Jonathan Berg, MD, PhD. The program, funded by a $10-million grant from UNC Health Care, will be a collaboration among multiple departments within the school to bring together existing precision medicine treatments and support future endeavors in this field.
Located in News / 2018 / October
New simple test could help cystic fibrosis patients find best treatment
In a significant step toward personalized medicine for cystic fibrosis, a minimally-invasive technique developed in the lab of Martina Gentzsch, PhD, shows promise as a fast, inexpensive indicator to help more patients access new treatments.
Located in News / 2017 / November
New therapeutic gel shows promise against cancerous tumors
The lab of Zhen Gu, PhD, in the joint UNC-NC State biomedical engineering department developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumor site.
Located in News / 2018 / February
Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.
Located in News / 2020 / March
Newly designed viral vectors could lead to improved gene therapies
UNC and University of Florida researchers created viruses to deliver gene therapies while evading pre-existing immune system responses. Aravind Asokan, PhD, led the research team at UNC.
Located in News / 2017 / June
Newsweek Lists UNC Medical Center & UNC REX Among World’s Best Hospitals
UNC Medical Center is ranked #50 in the United States, UNC REX is #148 on Newsweek's inaugural list of The World's Best Hospitals.
Located in News / 2019 / March
Novant Health, UNC Health and UNC School of Medicine announce intent to partner at New Hanover Regional Medical Center
Per the letter of intent, the organizations are committed to expanding the medical education program at New Hanover Regional Medical Center, including enhancing the long-standing pediatric program and other service lines as appropriate.
Located in News / 2020 / May
Pancreatic cancer tumor classification could optimize treatment choices
UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings on how two subtypes of pancreatic cancer respond to treatments differently. Importantly, they found that one subtype of the disease showed poor responses to common therapies, and also had worse survival rates.
Located in News / 2019 / November